Lyell Immunopharma, Inc. (LYEL) Revenue 2019–2025
Lyell Immunopharma, Inc. (LYEL) annual revenue history from SEC filings — each fiscal year as reported, with year-over-year change.
$36,000FY2025 · since FY2019: $657,000 → $36,000
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | $36,000 | -41.0% |
| FY2024 | $61,000 | -53.1% |
| FY2023 | $130,000 | -99.8% |
| FY2022 | $84.7M | +695.1% |
| FY2021 | $10.7M | +37.3% |
| FY2020 | $7.8M | +1080.5% |
| FY2019 | $657,000 | — |
Source: SEC XBRL filings · For reference only · Not investment advice